PEDIATRICS Vol. 83 No. 4 April 1989, pp. 513-518
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schuh, S.
Right arrow Articles by Soldin, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuh, S.
Right arrow Articles by Soldin, S. J.

High-Versus Low-Dose, Frequently Administered, Nebulized Albuterol in Children With Severe, Acute Asthma

Suzanne Schuh MD, FRCPC1, Patricia Parkin MD, FRCPC1, Aziza Rajan MB, ChB1, Gerald Canny MD, FRCPC1, Rosalean Healy MS, ChB1, Michael Rieder MD, SRCPC1, Yok K. Tan BSc1, Henry Levison MD, FRCPC1, and Steven J. Soldin PhD, FACB1

1 The Divisions of Emergency, Chest, and Clinical Pharmacology (Department of Paediatrics) and the Department of Biochemistry, The Hospital for Sick Children, Toronto

Thirty-two 5- to 17-year-old children who had severe, acute asthma were randomly assigned to receive either high doses (0.15 mg/kg of body weight per dose) or low doses (0.05 mg/kg of body weight per dose) of nebulized albuterol every 20 minutes for six doses. Compared with the low-dose regimen, the high-dose regimen resulted in significantly greater improvement in forced expiratory volume in 1 second, forced vital capacity, and wheeze score and a lower hospitalization rate. The changes in heart rate, respiratory rate, blood pressure, white blood cell count, and serum potassium concentration did not differ significantly between the groups. The incidence of side effects, which included tremor, hyperactivity, and vomiting, was not significantly different in the two populations. Serum albuterol levels varied widely, but there was no correlation between the levels and the increase in heart rate or other side effects. Highdose, frequently administered, nebulized albuterol appears both safe and effective in treating severe, acute asthma in children.

Key Words: asthma • albuterol • status asthmaticus

Submitted on March 18, 1988
Accepted on May 31, 1988




This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
C. D Ly and C. E Dennehy
Emergency Department Management of Pediatric Asthma at a University Teaching Hospital
Ann. Pharmacother., October 1, 2007; 41(10): 1625 - 1631.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
T. Elwood, W. Morris, L. D. Martin, M.-K. Nespeca, D. A. Wilson, L. A. Fleisher, J. L. Robotham, and D. G. Nichols
Bronchodilator premedication does not decrease respiratory adverse events in pediatric general anesthesia: [Une premedication bronchodilatatrice ne reduit pas les evenements respiratoires indesirables en anesthesie generale pediatrique]
Can J Anesth, March 1, 2003; 50(3): 277 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
H. W. Kelly
The Management of Acute Severe Asthma
Journal of Pharmacy Practice, April 1, 2001; 14(2): 91 - 107.
[Abstract] [PDF]

Home page
 NEJMHome page
S. Schuh, J. Reisman, M. Alshehri, A. Dupuis, M. Corey, R. Arseneault, G. Alothman, O. Tennis, and G. Canny
A Comparison of Inhaled Fluticasone and Oral Prednisone for Children with Severe Acute Asthma
N. Engl. J. Med., September 7, 2000; 343(10): 689 - 694.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. J. Gutglass, L. Hampers, G. Roosevelt, D. Teoh, S. R. Nimmagadda, and S. E. Krug
Undiluted Albuterol Aerosols in the Pediatric Emergency Department
Pediatrics, May 1, 2000; 105(5): 67e - 67.
[Abstract] [Full Text]

Home page
 J Intensive Care MedHome page
M. A. Jantz and N. A. Collop
Bronchodilator Aerosol Delivery in Mechanical Ventilation: Jantz MA, Collop NA Bronchodilator Aerosol Delivery in Mechanical Ventilation Intensive Care Med 1999,14 166-183
J Intensive Care Med, July 1, 1999; 14(4): 166 - 183.
[PDF]

Home page
 ChestHome page
C. L. Emerman, R. K. Cydulka, and E. R. McFadden
Comparison of 2.5 vs 7.5 mg of Inhaled Albuterol in the Treatment of Acute Asthma
Chest, January 1, 1999; 115(1): 92 - 96.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. V. Dobson, S. M. Stephens-Groff, S. R. McMahon, M. M. Stemmler, S. L. Brallier, and C. Bay
The Use of Albuterol in Hospitalized Infants With Bronchiolitis
Pediatrics, March 1, 1998; 101(3): 361 - 368.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
P. C. Stillwell
Keeping Ahead of Childhood Asthma
Clinical Pediatrics, February 1, 1993; 32(2): 97 - 99.
[PDF]

Home page
 CLIN PEDIATRHome page
J. A. Waler
Albuterol Dosage and Acute Asthma
Clinical Pediatrics, November 1, 1992; 31(11): 702 - 702.
[PDF]

Home page
 CLIN PEDIATRHome page
S. Press and R. S. Lipkind
A Treatment Protocol of the Acute Asthma Patient in a Pediatric Emergency Department
Clinical Pediatrics, October 1, 1991; 30(10): 573 - 577.
[Abstract] [PDF]